Outcome of men with ischemic cardiomyopathy, asymptomatic nonsustained ventricular tachycardia, and negative electrophysiologic studies

American Journal of Cardiology

Volumn 85, Issue 1, 2000, Pages 119-121

  Kim, Michael H ^a   Bruckman, David ^c   Kirsh, Marvin M ^b   Kou, William H ^a  

^a Section Ofcardiology   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c Innov Cost Effectiveness S ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; WARFARIN;

ADOLESCENT; ADULT; ARTICLE; CARDIOMYOPATHY; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE TACHYCARDIA; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SUDDEN DEATH;

AGED; ANALYSIS OF VARIANCE; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHIES; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TACHYCARDIA, VENTRICULAR; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 0033954564     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00622-0     Document Type: Article

References (10)

1. Buxton A.E., Marchlinski F.E., Flores B.T., Miller J.M., Doherty J.U., Josephson M.E. Nonsustained ventricular tachycardia in patients with coronary artery disease role of electrophysiologic study . Circulation. 75:1987;1178-1185.
2. Wilber D.J., Olshansky B., Moran J.F., Scanlon P.J. Electrophysiological testing and nonsustained ventricular tachycardia use and limitations in patients with coronary artery disease and impaired ventricular function . Circulation. 82:1990;350-358.
3. Kadish A., Schmaltz S., Calkins H., Morady F. Management of nonsustained ventricular tachycardia guided by electrophysiological testing. PACE. 16:1993;1037-1050.
4. Hammill S.C., Trusty J.M., Wood D.J., Bailey K.R., Vatterott P.J., Osborn M.J., Holmes D.R., Gersh B.J. Influence of ventricular function and presence or absence of coronary artery disease on results of electrophysiologic testing for asymptomatic nonsustained ventricular tachycardia. Am J Cardiol. 65:1990;722-728.
5. Hernandez M., Taylor J., Marinchak R., Rials S., Rubin A., Kowey P. Outcome of patients with nonsustained ventricular tachycardia and severely impaired ventricular function who have negative electrophysiologic studies. Am Heart J. 129:1995;492-496.
6. Kowey P.R., Waxman H.L., Greenspon A., Greenberg R., Poll D., Kutalek S., Gessman L., Muenz L. Value of electrophysiologic testing in patients with previous myocardial infarction and nonsustained ventricular tachycardia. Am J Cardiol. 65:1990;594-598.
7. Daubert J.P., Higgins S.L., Zareba W., Wilber D.J. Comparative survival of MADIT-eligible but noninducible patients. J Am Coll Cardiol. 29:(suppl A):1997;135A.
8. Giorgberidze I., Saksena S., Krol R.B., Munsif A.N., Kolettis T., Mathew P., Varanasi S., Prakash A., Delfaut P., Lewis C.B. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease a prospective single-center study . Am J Cardiol. 80:1997;3F-9F.
9. Hohnloser S.H., Franck P., Klingenheben T., Zabel M., Just H. Open infarct artery, late potentials, and other prognostic factors in patients after acute myocardial infarction in the thrombolytic era:a prospective trial. Circulation. 90:1994;1747-1756.
10. Opitz C.F., Finn P.V., Pfeffer M.A., Mitchell G.F., Pfeffer J.M. Effects of reperfusion on arrhythmias and death after coronary artery occlusion in the rat increased electrical stability independent of myocardial salvage . J Am Coll Cardiol. 32:1998;261-267.